HomeCompareSPAX vs JNJ

SPAX vs JNJ: Dividend Comparison 2026

SPAX yields 1.50% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPAX wins by $1.8K in total portfolio value
10 years
SPAX
SPAX
● Live price
1.50%
Share price
$20.28
Annual div
$0.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.8K
Annual income
$165.53
Full SPAX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPAX vs JNJ

📍 SPAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPAXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPAX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPAX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPAX
Annual income on $10K today (after 15% tax)
$127.66/yr
After 10yr DRIP, annual income (after tax)
$140.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $562.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPAX + JNJ for your $10,000?

SPAX: 50%JNJ: 50%
100% JNJ50/50100% SPAX
Portfolio after 10yr
$20.9K
Annual income
$496.66/yr
Blended yield
2.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPAX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPAX buys
0
JNJ buys
0
No recent congressional trades found for SPAX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPAXJNJ
Forward yield1.50%3.36%
Annual dividend / share$0.30$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.8K$20.0K
Annual income after 10y$165.53$827.78
Total dividends collected$1.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPAX vs JNJ ($10,000, DRIP)

YearSPAX PortfolioSPAX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,850$150.18$10,676$355.77+$174.00SPAX
2$11,762$152.29$11,407$389.39+$355.00SPAX
3$12,740$154.29$12,198$426.53+$542.00SPAX
4$13,788$156.18$13,056$467.62+$732.00SPAX
5$14,911$157.97$13,987$513.12+$924.00SPAX
6$16,114$159.66$14,998$563.56+$1.1KSPAX
7$17,403$161.26$16,098$619.52+$1.3KSPAX
8$18,784$162.77$17,295$681.69+$1.5KSPAX
9$20,263$164.19$18,599$750.82+$1.7KSPAX
10$21,847$165.53$20,022$827.78+$1.8KSPAX

SPAX vs JNJ: Complete Analysis 2026

SPAXStock

The fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities, specifically units and shares of common stock and warrants, of U.S.-listed Special Purpose Acquisition Companies (“SPACs”). A SPAC is publicly traded and is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more other operating companies. The fund is non-diversified.

Full SPAX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPAX vs SCHDSPAX vs JEPISPAX vs OSPAX vs KOSPAX vs MAINSPAX vs ABBVSPAX vs MRKSPAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.